Details of the Drug
General Information of Drug (ID: DMBF5KW)
| Drug Name |
4-nonylphenylboronic acid
|
||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Synonyms |
256383-45-6; 4-N-Nonylphenylboronic acid; 4-Nonylphenylboronic acid; (4-nonylphenyl)boronic Acid; 4-N-NONYLBENZENEBORONIC ACID; 4-N-Nonylphenylboronicacid; VONVJOGSLHAKOX-UHFFFAOYSA-N; AC1NEAO1; (4-nonylphenyl)boranediol; 4-nonylbenzene boronic acid; B-(4-Nonylphenyl)boronic acid; SCHEMBL3405525; CHEMBL485946; 4-(n-Nonyl)benzeneboronic Acid; BDBM26134; CTK8B1318; 1-Borono-4-(non-1-yl)benzene; DTXSID10404611; MolPort-000-931-545; Boronic acid,B-(4-nonylphenyl)-; 4-(Non-1-yl)benzeneboronic acid; ZX-AT001529; OR7244; CN-219
|
||||||||||||||||||||||
| Indication |
|
||||||||||||||||||||||
| Drug Type |
Small molecular drug
|
||||||||||||||||||||||
| Structure |
![]() |
||||||||||||||||||||||
| 3D MOL | 2D MOL | ||||||||||||||||||||||
| #Ro5 Violations (Lipinski): 0 |
Molecular Weight | 248.17 | |||||||||||||||||||||
| Logarithm of the Partition Coefficient | Not Available | ||||||||||||||||||||||
| Rotatable Bond Count | 9 | ||||||||||||||||||||||
| Hydrogen Bond Donor Count | 2 | ||||||||||||||||||||||
| Hydrogen Bond Acceptor Count | 2 | ||||||||||||||||||||||
| Chemical Identifiers |
|
||||||||||||||||||||||
| Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
| The Studied Disease | Discovery agent | |||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
| Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||


